Search Results - "KAWAGUCHI, TOSHIAKI"

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan by Narita, Shintaro, Hatakeyama, Shingo, Takahashi, Masahiro, Sakurai, Toshihiko, Kawamura, Sadafumi, Hoshi, Senji, Ishida, Masanori, Kawaguchi, Toshiaki, Ishidoya, Shigeto, Shimoda, Jiro, Sato, Hiromi, Koizumi, Atsushi, Mitsuzuka, Koji, Tochigi, Tatsuo, Tsuchiya, Norihiko, Ohyama, Chikara, Arai, Yoichi, Nomura, Kyoko, Habuchi, Tomonori

“…Purpose Clinical outcomes of patients with newly diagnosed metastatic hormone-naïve prostate cancer (mHNPC) and initially treated with androgen deprivation…”
Get full text

Long‐term disease control after upfront chemotherapy and surgery in a patient with primary prostate leiomyosarcoma by Kawaguchi, Toshiaki, Tanaka, Toshikazu, Ogasawara, Masaru, Ikuya, Iwabuchi

“…Introduction Prostate leiomyosarcoma is a rare, aggressive neoplasm. Case Presentation A 52‐year‐old man presented with worsening frequent micturition and…”
Get full text

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study by Kido, Koichi, Hatakeyama, Shingo, Numakura, Kazuyuki, Tanaka, Toshikazu, Oikawa, Masaaki, Noro, Daisuke, Hosogoe, Shogo, Narita, Shintaro, Inoue, Takamitsu, Yoneyama, Takahiro, Ito, Hiroyuki, Nishimura, Shoji, Hashimoto, Yasuhiro, Kawaguchi, Toshiaki, Habuchi, Tomonori, Ohyama, Chikara

“…Background This study compared real-world outcomes of metastatic renal-cell carcinoma (mRCC) patients treated with tyrosine kinase inhibitors or nivolumab plus…”
Get full text

Efficacy and safety of first‐line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study by Tanaka, Toshikazu, Hatakeyama, Shingo, Numakura, Kazuyuki, Kido, Koichi, Noro, Daisuke, Oikawa, Masaaki, Hosogoe, Shogo, Tokui, Noriko, Yamamoto, Hayato, Narita, Shintaro, Ito, Hiroyuki, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Kawaguchi, Toshiaki, Habuchi, Tomonori, Ohyama, Chikara

“…Objectives To investigate the efficacy and safety of first‐line nivolumab plus ipilimumab for patients treated with metastatic renal cell carcinoma. Methods We…”
Get full text

Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study by Okamoto, Teppei, Noro, Daisuke, Hatakeyama, Shingo, Narita, Shintaro, Mitsuzuka, Koji, Sakurai, Toshihiko, Kawamura, Sadafumi, Hoshi, Senji, Shimoda, Jiro, Tanaka, Toshikazu, Kawaguchi, Toshiaki, Ishidoya, Shigeto, Ito, Akihiro, Tsuchiya, Norihiko, Habuchi, Tomonori, Ohyama, Chikara

“…Background Anemia has been a known prognostic factor in metastatic hormone-sensitive prostate cancer (mHSPC). We therefore examined the effect of anemia on the…”
Get full text

C‐reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma by Konishi, Sakae, Hatakeyama, Shingo, Tanaka, Toshiaki, Ikehata, Yoshinori, Tanaka, Toshikazu, Hamano, Itsuto, Fujita, Naoki, Yoneyama, Tohru, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Yoshikawa, Kazuaki, Kawaguchi, Toshiaki, Masumori, Naoya, Kitamura, Hiroshi, Ohyama, Chikara

“…Objectives To evaluate the effect of pretreatment C‐reactive protein/albumin ratio and modified Glasgow prognostic score on the prognosis in patients with…”
Get full text

Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration‐sensitive prostate cancer: A multicenter retrospective study by Hatakeyama, Shingo, Narita, Shintaro, Takahashi, Masahiro, Sakurai, Toshihiko, Kawamura, Sadafumi, Hoshi, Senji, Ishida, Masanori, Kawaguchi, Toshiaki, Ishidoya, Shigeto, Shimoda, Jiro, Sato, Hiromi, Hamano, Itsuto, Okamoto, Teppei, Mitsuzuka, Koji, Ito, Akihiro, Tsuchiya, Norihiko, Arai, Yoichi, Habuchi, Tomonori, Ohyama, Chikara

“…Objectives To evaluate the association of tumor burden with the prognosis in real‐world patients with metastatic castration‐sensitive prostate cancer and to…”
Get full text

Frailty is significantly associated with the type of urinary diversion in patients with muscle‐invasive bladder cancer by Okita, Kazutaka, Hatakeyama, Shingo, Momota, Masaki, Soma, Osamu, Hamano, Itsuto, Tanaka, Toshikazu, Iwamura, Hiromichi, Fujita, Naoki, Okamoto, Teppei, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Yoshikawa, Kazuaki, Kawaguchi, Toshiaki, Ohyama, Chikara

“…Objectives To investigate the effect of frailty on the type of urinary diversion after radical cystectomy in patients with muscle‐invasive bladder cancer…”
Get full text

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma by Kido, Koichi, Hatakeyama, Shingo, Fujita, Naoki, Yamamoto, Hayato, Tobisawa, Yuki, Yoneyama, Tohru, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Koie, Takuya, Iwabuchi, Ikuya, Ogasawara, Masaru, Kawaguchi, Toshiaki, Ohyama, Chikara

“…Background Oncologic benefits of laparoscopic radical nephroureterectomy (LNU) are unclear. We aimed to evaluate the impact of surgical approach for radical…”
Get full text

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis by Konishi, Sakae, Hatakeyama, Shingo, Tanaka, Toshiaki, Ikehata, Yoshinori, Tanaka, Toshikazu, Fujita, Naoki, Ishibashi, Yusuke, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Yoshikawa, Kazuaki, Kawaguchi, Toshiaki, Masumori, Naoya, Kitamura, Hiroshi, Ohyama, Chikara

“…We aimed to compare oncological outcomes and safety of axitinib and sunitinib in patients with treatment-naïve metastatic renal cell carcinoma (mRCC). We…”
Get full text

The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy by Murasawa, Hiromi, Koie, Takuya, Ohyama, Chikara, Yamamoto, Hayato, Imai, Atsushi, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Iwabuchi, Ikuya, Ogasawara, Masaru, Kawaguchi, Toshiaki

“…Background There are currently no data supporting carboplatin-based regimens in muscle-invasive bladder cancer patients who are unsuitable for neoadjuvant…”
Get full text

Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy by Narita, Shintaro, Nomura, Kyoko, Hatakeyama, Shingo, Takahashi, Masahiro, Sakurai, Toshihiko, Kawamura, Sadafumi, Hoshi, Senji, Ishida, Masanori, Kawaguchi, Toshiaki, Ishidoya, Shigeto, Shimoda, Jiro, Sato, Hiromi, Mitsuzuka, Koji, Tochigi, Tatsuo, Tsuchiya, Norihiko, Ohyama, Chikara, Arai, Yoichi, Nagashima, Kengo, Habuchi, Tomonori

“…Background The purpose of this study was to identify predictive factors associated with conditional net survival in patients with metastatic hormone‐naive…”
Get full text

A Case Of Cystic Pheochromocytoma With Hypertension And Headaches Mimicking A Large Pancreatic Cystic Tumor by Yamagata, Satoshi, Kageyama, Kazunori, Nomura, Ayami, Murasawa, Shingo, Ogasawara, Masaru, Kawaguchi, Toshiaki, Tazawa, Yasuaki, Ogawa, Yoshiji

“…Objective: Cystic pheochromocytomas can become enlarged without abdominal symptoms and can potentially be confused with other abdominal cystic tumors.Methods:…”
Get full text

Venous Cerebral Infarction in a Patient With Peripheral Hemodialysis Shunt and Occlusion of the Left Brachiocephalic Vein by Nishijima, Haruo, MD, Tomiyama, Masahiko, MD, PhD, Haga, Rie, MD, Ueno, Tatsuya, MD, Miki, Yasuo, MD, Arai, Akira, MD, PhD, Kimura, Tamaki, MD, PhD, Suzuki, Chieko, MD, PhD, Nunomura, Jin-ichi, MD, PhD, Kakehata, Shinya, MD, Kawaguchi, Toshiaki, MD, PhD, Baba, Masayuki, MD, PhD

“…Intracranial venous congestion is a rare condition in hemodialysis patients with central venous occlusion. We report a patient with cerebral venous infarction…”
Get full text

Therapeutic effects of long-term administration of an oral adsorbent in patients with chronic renal failure: two-year study by TAKAHASHI, NOBUYOSHI, KAWAGUCHI, TOSHIAKI, SUZUKI, TADASHI

“…Background:  Kremezin is an oral adsorbent that attenuates the progression of chronic renal failure by removing uremic toxins and their precursors from the…”
Get full text

Chemo-endocrine therapy with low-dose cisplatin, UFT, and dexamethasone for hormone-refractory prostate cancer patients by Kawaguchi, Toshiaki, Mayama, Ikumi, Iwabuchi, Ikuya, Ogasawara, Masaru, Tsukui, Atsushi

“…Since September 2005, twenty-two patients with hormone-refractory prostate cancer (aged 55-81 years) were treated with LH-RH agonist and low-dose cisplatin,…”
Get more information

Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan by Okamoto, Teppei, Hatakeyama, Shingo, Narita, Shintaro, Takahashi, Masahiro, Sakurai, Toshihiko, Kawamura, Sadafumi, Hoshi, Senji, Ishida, Masanori, Kawaguchi, Toshiaki, Ishidoya, Shigeto, Shimoda, Jiro, Sato, Hiromi, Mitsuzuka, Koji, Tochigi, Tatsuo, Tsuchiya, Norihiko, Arai, Yoichi, Habuchi, Tomonori, Ohyama, Chikara

“…Purpose To investigate the association between the Geriatric Nutritional Risk Index (GNRI) and prognosis of patients with metastatic hormone-naïve prostate…”
Get full text

MP82-09 THE IMPACT OF NEOADJUVANT CHEMOTHERAPY ON LOCALLY ADVANCED UPPER TRACT UROTHELIAL CARCINOMA: A MULTICENTER STUDY by Kubota, Yuka, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Ito, Hiroyuki, Yoshikawa, Kazuaki, Sasaki, Atsushi, Kawaguchi, Toshiaki, Ohyama, Chikara

Get full text

Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy by Kamimura, Noritaka, Hatakeyama, Shingo, Kudo, Shigemasa, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Koie, Takuya, Yoshikawa, Kazuaki, Kawaguchi, Toshiaki, Takahashi, Shinya, Ohyama, Chikara

“…The efficacy and safety of additional administration of propiverine were prospectively studied for naftopidil-resistant nocturia in patients with benign…”
Get full text

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study by Kubota, Yuka, Hatakeyama, Shingo, Tanaka, Toshikazu, Fujita, Naoki, Iwamura, Hiromichi, Mikami, Jotaro, Yamamoto, Hayato, Tobisawa, Yuki, Yoneyama, Tohru, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Koie, Takuya, Ito, Hiroyuki, Yoshikawa, Kazuaki, Sasaki, Atsushi, Kawaguchi, Toshiaki, Ohyama, Chikara

“…The clinical impact of neoadjuvant chemotherapy (NAC) on oncological outcomes in patients with locally advanced upper tract urothelial carcinoma (UTUC) remains…”
Get full text